Actuate Therapeutics (ACTU) Stock Chart & Stock Price History $7.26 +0.27 (+3.86%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$7.26 0.00 (0.00%) As of 07/25/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Actuate Therapeutics Stock Price Performance The Actuate Therapeutics (ACTU) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 8.79%. In the past month, the stock has increased 21.81%, reflecting recent market activity. As of the latest close, Actuate Therapeutics traded at $7.26 with a market cap of $142.44 million and volume of 100,376 shares. Receive ACTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+15.97%1 Month Performance+21.81%3 Month Performance-18.88%Year-To-Date Performance-8.79% ACTU Stock Chart for Sunday, July, 27, 2025 ACTU Chart by TradingView Actuate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$6.99$7.26+3.86%$7.28$6.49100,376 shs$142.44 million07/24/2025$6.60$6.99+5.91%$7.10$6.45123,332 shs$137.14 million07/23/2025$6.26$6.60+5.43%$6.70$6.22153,864 shs$129.49 million07/22/2025$5.66$6.26+10.60%$6.29$5.5892,586 shs$122.82 million07/21/2025$5.76$5.66-1.74%$5.98$5.4777,677 shs$111.05 million07/18/2025$6.26$5.76-7.99%$6.21$5.7687,198 shs$113.01 million07/17/2025$6.23$6.26+0.48%$7.33$6.00618,575 shs$122.82 million07/16/2025$5.97$6.23+4.36%$6.32$5.9246,688 shs$122.23 million07/15/2025$6.20$5.97-3.71%$6.26$5.9745,608 shs$117.13 million07/14/2025$6.14$6.20+0.98%$6.30$6.0365,268 shs$121.64 million Get the Latest News and Ratings for ACTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$6.18$6.14-0.65%$6.29$6.0224,386 shs$120.47 million07/10/2025$6.61$6.18-6.51%$6.64$6.1634,842 shs$121.25 million07/09/2025$6.24$6.61+5.93%$6.61$6.0368,037 shs$129.69 million07/08/2025$6.01$6.24+3.83%$6.53$5.70127,996 shs$122.43 million07/07/2025$6.53$6.01-7.89%$6.75$6.0171,487 shs$117.92 million07/04/2025$6.53$6.53$6.79$6.2653,986 shs$128.02 million07/03/2025$6.74$6.53-3.19%$6.79$6.2653,986 shs$128.02 million07/02/2025$6.13$6.74+9.95%$6.87$6.03131,134 shs$132.24 million07/01/2025$6.11$6.13+0.33%$6.39$5.80260,809 shs$120.27 million06/30/2025$5.96$6.11+2.52%$6.75$5.60248,403 shs$119.88 million06/27/2025$5.82$5.96+2.41%$6.50$5.50966,466 shs$116.94 million06/26/2025$6.44$5.82-9.63%$6.74$5.6977,013 shs$114.19 million Related Companies CGEM Stock Chart KMDA Stock Chart ERAS Stock Chart AQST Stock Chart CMPX Stock Chart FULC Stock Chart RGNX Stock Chart TECX Stock Chart MBX Stock Chart SNDL Stock Chart Receive ACTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACTU) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actuate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actuate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
